✓ No active regulatory warningsFDA MedWatch, EMA EudraVigilance, WHO VigiBase, WADA Prohibited List · 2026-05-29
📰Read the full Glucosamine evidence review on GMJ News →Complete clinical article, references and updates on news.gmj.ge. This page is the structured safety summary.⚠ Patient using glucosamine HCl — this is the form that failed GAIT; switch to crystalline glucosamine sulfate [2] [3]
⚠ Patient on warfarin — case reports of INR increase; monitor [1]
⚠ GAIT subgroup: glucosamine + chondroitin worked for moderate-severe knee OA pain [2]
⚠ Shellfish allergy: purified glucosamine is likely safe, but synthetic versions available [1]
ℹ️ Not obtained from food. Not applicable — this is not obtained from food in meaningful amounts; supplementation is the practical route.
🔬 Lab interpreter
Recommended test
No routine monitoring
No routine monitoring
Reference range / target
N/A
N/A
Clinical pain assessment and functional outcomes [3].
Full lab monitoring ↓⚕ For professionals — confirm ranges against your local laboratory.
Clinical verdict
The salt form is EVERYTHING: glucosamine SULFATE (Rotta/pharmaceutical-grade) has positive European trial data; glucosamine HCl FAILED in the GAIT trial. They are NOT interchangeable. 1,500 mg/day sulfate form, 4–8 weeks for effect. GAIT combination subgroup (moderate-severe OA) showed benefit with glucosamine + chondroitin [2] [3].
1 How much do I need?
👤 Adults: Specific dosage data under clinical review
👴 Elderly: Specific dosage data under clinical review
🤰 Pregnancy: See guidance
Limited data. Generally considered safe. Consult physician [1].
👦 Pediatric: See guidance
No pediatric data. Not recommended for children (OA is an adult condition) [1].
🏃 Athletes: Standard dose
⚖️ Obesity: Standard dose
Fat-soluble compounds may require dose adjustment in obesity.
🩺 Renal: Consult specialist
Dose adjustment may be needed in renal impairment.
🌱 Vegan: Standard dose
How to take
🍽 Timing: 1,500 mg once daily (or divided TID). Can be taken with or without food [3].
💊 With food: No specific requirement [1].
🚫 Avoid: Warfarin without INR monitoring [1].
2 Which form?
| Form | Bioavailability | Vegan | Cost |
|---|---|---|---|
| ['Crystalline glucosamine sulfate (Rotta/Rottapharm)', 'preferred', 'Pharmaceutical-grade. The ONLY form with consistent positive trial data (GUIDE, GAIT subgroup). 1,500 mg once daily [3].'] | Standard | Check label | |
| ['Glucosamine HCl', 'common', 'Higher glucosamine content per mg (83% vs 65% in sulfate). BUT this is the form that FAILED in the GAIT trial. Less evidence [2].'] | Standard | Check label | |
| ['Glucosamine + chondroitin combination', 'common', 'GAIT showed the combination was effective in a subgroup with moderate-severe pain (p=0.002), though the primary endpoint was negative [2].'] | Standard | Check label | |
| ['N-Acetyl glucosamine', '', 'Different compound. Less studied for OA. Some GI/immune research [1].'] | Standard | Check label |
3 Common questions
Why did GAIT fail but European trials succeed? ▼
Does glucosamine actually rebuild cartilage? ▼
The European 3-year trials with glucosamine sulfate showed reduced joint space narrowing on X-ray, suggesting structural preservation [3]. This does not mean cartilage is 'rebuilt' — rather, degradation may be slowed. The effect is modest.
Should I take glucosamine with chondroitin? ▼
Is shellfish allergy a concern? ▼
Glucosamine from shellfish shells is purified protein-free. Most allergists consider it safe for shellfish-allergic individuals (the allergy is to muscle protein, not chitin) [1]. Synthetic versions exist for those who prefer to avoid shellfish entirely.
4 Clinical evidence
Strong
GAIT trial (n=1,583): glucosamine HCl 1,500 mg/day was NOT superior to placebo for the primary endpoint (knee OA pain) [2]. This is the definitive negative result for the HCl form. The combination of glucosamine + chondroitin DID show benefit in the moderate-severe pain subgroup (p=0.002) [2]. HIGH
Moderate
Crystalline glucosamine sulfate (Rotta): the GUIDE trial and other European RCTs showed symptom reduction comparable to celecoxib and structural preservation (joint space narrowing reduction) over 3 years [3]. The discrepancy with GAIT is attributed to the different salt form. OARSI and ESCEO guidelines conditionally recommend glucosamine sulfate for knee OA [3]. Chondroitin sulfate 800 mg/day: some evidence for pain reduction and structural benefit [1]. MODERATE
Insufficient
5 Safety, toxicity & adverse events
Relative
⚠ Shellfish allergy — most glucosamine is derived from crab/shrimp shells (synthetic and corn-based alternatives available)
⚠ Concurrent warfarin — case reports of increased INR
⚠ Diabetes — glucosamine may worsen glycemic control (conflicting evidence)
⚠ Asthma — rare reports of exacerbation
🚩 Red flags
● Patient on warfarin + glucosamine — monitor INR [1]
● Patient using glucosamine HCl instead of sulfate — explain the evidence difference [2] [3]
6 Interactions
Drug interactions
Warfarin Moderate
Mechanism: Case reports of increased INR. Mechanism unclear — may affect vitamin K metabolism or CYP2C9. [1]
Effect: Increased bleeding risk. [1]
Action: Monitor INR within 1–2 weeks of starting glucosamine [1].
Supplement synergies
Chondroitin sulfate · 800–1,200 mg/day
GAIT subgroup showed benefit. Common combination. Both are GAG precursors [2].
GAIT subgroup showed benefit. Common combination. Both are GAG precursors [2].
Collagen Peptides · 5–10 g/day
Complementary cartilage support — glucosamine (GAGs) + collagen (structural protein) [1].
Complementary cartilage support — glucosamine (GAGs) + collagen (structural protein) [1].
Omega-3 fatty acids · 1–2 g/day EPA+DHA
Anti-inflammatory (EPA) + structural support (glucosamine) [1].
Anti-inflammatory (EPA) + structural support (glucosamine) [1].
7 Regulatory
United States (FDA): Dietary supplement. No approved health claims [1].
European Union: Crystalline glucosamine sulfate is a prescription drug in several EU countries (Italy, Spain, Portugal) [3].
ESCEO guidelines: Conditionally recommend pharmaceutical-grade glucosamine sulfate for knee OA (Step 1 treatment) [3].
South Korea: Available as dietary supplement and pharmaceutical.
8 US supplement products
48
on-market products containing Glucosamine (NIH DSLD)
Brands carrying Glucosamine (13)
Click a brand to see its Glucosamine products.
9 Frequently paired with
10 Cite this page
Vancouver: Pkhakadze G. Glucosamine — safety profile [Internet]. Tbilisi: PHIG; 2026 [cited 2026 Aug 15]. Available from: https://supplement.ge/ingredients/glucosamine/
APA 7th: Pkhakadze, G. (2026). Glucosamine — Safety profile. Public Health Institute of Georgia. https://supplement.ge/ingredients/glucosamine/
📋 Editorial information
Author: Prof. G. Pkhakadze, MD, MPH, PhD
Institution: Public Health Institute of Georgia (PHIG)
Affiliation: David Tvildiani Medical University (DTMU)
First published: January 2026
Last reviewed: 2026-05-29
Next review: February 2027
References: 3 cited sources
COI: SupplementIndex receives no funding from supplement manufacturers. All content independently authored by PHIG.
Process: Systematic literature review
📄 License & reuse
Published under Creative Commons Attribution 4.0 International (CC BY 4.0). You may share and adapt for any purpose with attribution.
Pkhakadze G. "Glucosamine — Safety Profile." SupplementIndex, PHIG, 2026. https://supplement.ge/ingredients/glucosamine/ CC BY 4.0.
GP
Prof. G. Pkhakadze, MD, MPH, PhD
Professor of Public Health · Head of Department, DTMU
Editor-in-Chief, Georgian Medical Journal (ISSN 3088-4322)
Chair, Public Health Institute of Georgia · UEMS Public Health Section
Educational and public health purposes. CC BY 4.0. Consult your healthcare provider before starting any supplement. Corrections: info@accreditation.ge. Publisher: PHIG